JP2001181179A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001181179A5 JP2001181179A5 JP1999364912A JP36491299A JP2001181179A5 JP 2001181179 A5 JP2001181179 A5 JP 2001181179A5 JP 1999364912 A JP1999364912 A JP 1999364912A JP 36491299 A JP36491299 A JP 36491299A JP 2001181179 A5 JP2001181179 A5 JP 2001181179A5
- Authority
- JP
- Japan
- Prior art keywords
- gelatin
- dialysis
- dialysate
- manufactured
- molecular weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000159 gelatin Polymers 0.000 description 22
- 235000019322 gelatine Nutrition 0.000 description 22
- 235000011852 gelatine desserts Nutrition 0.000 description 22
- 108010010803 Gelatin Proteins 0.000 description 21
- 239000008273 gelatin Substances 0.000 description 21
- 238000000502 dialysis Methods 0.000 description 14
- 230000003204 osmotic Effects 0.000 description 9
- 239000002357 osmotic agent Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 108010093096 Immobilized Enzymes Proteins 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000000890 antigenic Effects 0.000 description 4
- 230000002255 enzymatic Effects 0.000 description 4
- 101700086558 CELA1 Proteins 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 101710014338 eglS Proteins 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 206010038435 Renal failure Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 229960004316 cisplatin Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000004059 degradation Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 230000001954 sterilising Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- LXZZYRPGZAFOLE-UHFFFAOYSA-L transplatin Chemical compound [H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H] LXZZYRPGZAFOLE-UHFFFAOYSA-L 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000020504 Collagenase family Human genes 0.000 description 1
- 108060005980 Collagenase family Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 229960003531 Phenolsulfonphthalein Drugs 0.000 description 1
- 210000002381 Plasma Anatomy 0.000 description 1
- 206010040560 Shock Diseases 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000172 allergic Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000065 osmolyte Effects 0.000 description 1
- 239000000546 pharmaceutic aid Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002797 proteolythic Effects 0.000 description 1
- 231100000197 serious side effect Toxicity 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002522 swelling Effects 0.000 description 1
- 229960005486 vaccines Drugs 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP36491299A JP2001181179A (ja) | 1999-12-22 | 1999-12-22 | 低抗原性ゼラチンからなる浸透圧剤およびそれを含有する薬剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP36491299A JP2001181179A (ja) | 1999-12-22 | 1999-12-22 | 低抗原性ゼラチンからなる浸透圧剤およびそれを含有する薬剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001181179A JP2001181179A (ja) | 2001-07-03 |
| JP2001181179A5 true JP2001181179A5 (de) | 2005-10-13 |
Family
ID=18482973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP36491299A Pending JP2001181179A (ja) | 1999-12-22 | 1999-12-22 | 低抗原性ゼラチンからなる浸透圧剤およびそれを含有する薬剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001181179A (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100360194C (zh) * | 2004-09-30 | 2008-01-09 | 广州明兴制药有限公司 | 一种无醋酸的碳酸氢盐血液透析剂 |
| EP1890686B1 (de) | 2005-05-30 | 2017-10-04 | Fresenius Medical Care Deutschland GmbH | Peritonealdialyseflüssigkeit |
| JP5016830B2 (ja) * | 2006-03-17 | 2012-09-05 | ゼライス株式会社 | ペプチド精製物の製造方法 |
| JP5237714B2 (ja) * | 2008-07-29 | 2013-07-17 | ＢｉｏＲＯＩＳ株式会社 | 細胞輸送用担体及びそれを使用した細胞の輸送方法 |
-
1999
- 1999-12-22 JP JP36491299A patent/JP2001181179A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2169451C (en) | Biochemically balanced peritoneal dialysis solutions | |
| JP5286208B2 (ja) | 改質したイコデキストリンを含む腹膜透析溶液 | |
| US4308255A (en) | Balanced oncotic pressure fluid | |
| EP0078832B1 (de) | Dialyselösung enthaltendes glycerol | |
| Kolff | The artificial kidney—past, present, and future | |
| TW200422045A (en) | Biocompatible dialysis fluids containing icodextrins | |
| Ronco et al. | First clinical experience with an adjunctive hemoperfusion device designed specifically to remove β2-microglobulin in hemodialysis | |
| EP0914093A1 (de) | Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten | |
| RU2118531C1 (ru) | Фармацевтическая композиция для перитонеального диализа | |
| JP2001181179A5 (de) | ||
| CA3130651A1 (en) | Blood treatment device comprising alkaline phosphatase | |
| CN115746408A (zh) | 用于腹膜透析的新颖的葡萄糖聚合物 | |
| JP2003339853A (ja) | 安定な透析用剤 | |
| JPH1171273A (ja) | 腹膜透析液 | |
| JP2004016615A (ja) | 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液 | |
| Coles | Biocompatibility of various osmotic solutes | |
| JP2722131B2 (ja) | 腹膜透析液 | |
| EP1915127A1 (de) | Filtratzusammensetzung mit strahlenabsorber | |
| CN101322934A (zh) | 内毒素吸附剂的制备方法 | |
| Kerr | The Uremic Syndrome as Modified by Replacement of Renal Function |